Whole cell vaccine (Oncbiomune)

全细胞疫苗

Report date: 2022/02/17 16:52:03

Base Information

Drug NameWhole cell vaccine (Oncbiomune)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin-2 stimulantsMacrophage colony stimulating factor 2 stimulants
TargetsInterleukin-2Colony stimulating factorMacrophage colony stimulating factor 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncbiomune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncbiomune
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A